No doubt about CVSI's growth and the market demand for CBD...BUT, I believe, at this point in the game, that the failure to uplist will tarnish them beyond repair. I will continue to play the devils advocate until they come through and the up-listing is approved as I believe it is very important, they wont flourish on the OTC as they would on NASDAQ plain and simple.
Market Data 
Markets 
AI
